Company: MYSZ
Filing Date: 2025-07-08
Form Type: DEF 14A
Source: 0001641172-25-018202
Chunk: 23

Company: My Size, Inc.
Filing Date: 2025-07-08
Form: DEF 14A
Chunk 23
---
 to purchase up to 800 shares of our common stock which are held by Mr. Luzon. Ms. Pardo may be deemed to beneficially hold the securities of the Company held by Mr. Luzon.

(6) Consists of (i) 7,965 shares of our common
stock and (ii) options to purchase up to 1,958 shares of our common stock.

(7)Consists of (i) options to purchase up to 150 shares of our common stock and (ii) 2,500 shares of restricted stock.

(8)Consists of (i) options to purchase up to 150 shares of our common stock and (ii) 2,500 shares of restricted stock.

(9)Consists of 2,500 shares of restricted stock.

<div align='center'>EXECUTIVE COMPENSATION AND OTHER INFORMATION</div>

The following table sets forth certain information about our executive officers:

| Name                     |     | Age |     | Position                                    |
| Ronen                    
 Luzon                    |     |  55 |     | Chief                                       
 Executive Officer and Director              |
| Oren                     
 Elmaliah                 |     |  41 |     | Chief                                       
 Financial Officer                           |
| Billy                    
 Pardo                    |     |  50 |     | Chief                                       
 Operating Officer and Chief Product Officer |
| Borja Cembrero Saralegui |     |  33 |     | Chief Growth Officer                        |

Ronen Luzon — Founder, Director & Chief Executive Officer

Mr. Luzon’s biography is listed under Proposal 1—Election of Directors.

| 12 |

Oren Elmaliah — Chief Financial Officer

Oren Elmaliahserved as a member of our board of directors since May 2017 until March 2025. Effective April 1, 2025, Mr. Elmaliah was appointed as our Chief Financial Officer. In September 2015, Oren Elmaliah founded Accounting Team IL and has acted as Account Manager since then. Accounting Team IL is a financial consultancy and service provider to public companies traded in Israel and abroad. Since February 2017, Mr. Elmaliah has served as controller of Enlivex Therapeutics Ltd., and since January 2017 he has served as Chief Financial Officer of Presstek Israel. In addition, since September 2015, Mr. Elmaliah has served as an Israel Authorities Reporting Officer of LG Electronics Israel and since September 201